[{"type":"table","placeholders":{"clientName":"EY","metricName":"Twitter Questions Table | All Pages","timePeriod":"03\/31\/2021 - 04\/14\/2021","interval":"total","notes":""},"metaData":{"columns":[{"id":"createTime","title":"Question","type":"twitterQuestion","width":0.5},{"id":"timeToRespond","title":"Response Time","type":"responseTime","width":0.25},{"id":"retweets","title":"Retweets","type":"integer","width":0.12},{"id":"favs","title":"Likes","type":"integer","width":0.12}],"paginate":true,"sortBy":"createTime","sortDir":"DESC"},"data":[{"pageName":"@PwCUS","createTime":"<b>@PwCUS<\/b> was asked by <b>@Xbordertax - 2021-04-14 16:23:51<\/b><br \/> Did you miss my podcast with @PwCUS's tax leader where she shared how her mom has influenced her career? It's now a\u2026 https:\/\/t.co\/aKEEdEDilD","userName":"@Xbordertax","message":"Did you miss my podcast with @PwCUS's tax leader where she shared how her mom has influenced her career? It's now a\u2026 https:\/\/t.co\/aKEEdEDilD","link":"https:\/\/twitter.com\/Xbordertax\/status\/1382338817680666627","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@DeloitteUS","createTime":"<b>@DeloitteUS<\/b> was asked by <b>@TheRealValRain - 2021-04-14 15:03:31<\/b><br \/> How can you lead toward #RacialEquity? \nYou can start by reading \u201cThe equity imperative\u201d from @DeloitteUS \u2014\nI\u2019m a p\u2026 https:\/\/t.co\/YbZsYC98i7","userName":"@TheRealValRain","message":"How can you lead toward #RacialEquity? \nYou can start by reading \u201cThe equity imperative\u201d from @DeloitteUS \u2014\nI\u2019m a p\u2026 https:\/\/t.co\/YbZsYC98i7","link":"https:\/\/twitter.com\/TheRealValRain\/status\/1382318600657248267","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@PwCUS","createTime":"<b>@PwCUS<\/b> was asked by <b>@DanielEBennett - 2021-04-13 23:36:35<\/b><br \/> @PwCUS \"Upskilling\"? Is that wokespeak?","userName":"@DanielEBennett","message":"@PwCUS \"Upskilling\"? Is that wokespeak?","link":"https:\/\/twitter.com\/DanielEBennett\/status\/1382085331839635456","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@JoeBailitz - 2021-04-13 22:12:03<\/b><br \/> What happens when SPACs cross borders? Listen to our new KPMG Financial Reporting #Podcast where @KPMG_US professio\u2026 https:\/\/t.co\/6nG00idpJi","userName":"@JoeBailitz","message":"What happens when SPACs cross borders? Listen to our new KPMG Financial Reporting #Podcast where @KPMG_US professio\u2026 https:\/\/t.co\/6nG00idpJi","link":"https:\/\/twitter.com\/JoeBailitz\/status\/1382064056903766016","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@PwCUS","createTime":"<b>@PwCUS<\/b> was asked by <b>@MarkSpradley - 2021-04-13 20:39:12<\/b><br \/> @PwCUS Can you provide a description of the image?","userName":"@MarkSpradley","message":"@PwCUS Can you provide a description of the image?","link":"https:\/\/twitter.com\/MarkSpradley\/status\/1382040689517678593","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@PwCUS","createTime":"<b>@PwCUS<\/b> was asked by <b>@DonaldPJames - 2021-04-13 19:20:03<\/b><br \/> Will institutions make CX or payments \u2018plumbing\u2019 their business? Alie Hoover, @PwCUS's Banking Transformation Leade\u2026 https:\/\/t.co\/xlgGjs3Yay","userName":"@DonaldPJames","message":"Will institutions make CX or payments \u2018plumbing\u2019 their business? Alie Hoover, @PwCUS's Banking Transformation Leade\u2026 https:\/\/t.co\/xlgGjs3Yay","link":"https:\/\/twitter.com\/DonaldPJames\/status\/1382020773007683584","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@DeloitteUS","createTime":"<b>@DeloitteUS<\/b> was asked by <b>@RyanReplogle - 2021-04-13 18:00:07<\/b><br \/> @DeloitteUS By any chance, could one of your auditors participate in a short email interview with me for my business law class?","userName":"@RyanReplogle","message":"@DeloitteUS By any chance, could one of your auditors participate in a short email interview with me for my business law class?","link":"https:\/\/twitter.com\/RyanReplogle\/status\/1382000657717137410","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@EY_US","createTime":"<b>@EY_US<\/b> was asked by <b>@RyanReplogle - 2021-04-13 17:58:25<\/b><br \/> @EY_US Any chance one of your auditors could possibly participate in a short email interview with me for my business law class?","userName":"@RyanReplogle","message":"@EY_US Any chance one of your auditors could possibly participate in a short email interview with me for my business law class?","link":"https:\/\/twitter.com\/RyanReplogle\/status\/1382000229222912001","retweets":"0","favs":"0","respTime":"04\/13\/2021 19:31:30","timeToRespond":"04\/13\/2021 19:31:30"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@JimSullivan0310 - 2021-04-13 08:29:30<\/b><br \/> What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/owmIKyVK99 https:\/\/t.co\/VLi1QZ5bOU","userName":"@JimSullivan0310","message":"What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/owmIKyVK99 https:\/\/t.co\/VLi1QZ5bOU","link":"https:\/\/twitter.com\/JimSullivan0310\/status\/1381857054361444352","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@mbearup1 - 2021-04-13 01:17:33<\/b><br \/> What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/slWvZAdvib https:\/\/t.co\/KAMP8pFM3x","userName":"@mbearup1","message":"What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/slWvZAdvib https:\/\/t.co\/KAMP8pFM3x","link":"https:\/\/twitter.com\/mbearup1\/status\/1381748352644050945","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@kalen230 - 2021-04-13 00:51:29<\/b><br \/> \ud83e\udd1a Need tax help with #ASC740? Read the updated guide from @KPMG_US Department of Professional Practice \u2013 explaining\u2026 https:\/\/t.co\/kdyImbaz49","userName":"@kalen230","message":"\ud83e\udd1a Need tax help with #ASC740? Read the updated guide from @KPMG_US Department of Professional Practice \u2013 explaining\u2026 https:\/\/t.co\/kdyImbaz49","link":"https:\/\/twitter.com\/kalen230\/status\/1381741793239134209","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@PwCUS","createTime":"<b>@PwCUS<\/b> was asked by <b>@JamayBeebe - 2021-04-12 21:46:17<\/b><br \/> Will institutions make CX or payments \u2018plumbing\u2019 their business? Alie Hoover, @PwCUS's Banking Transformation Leade\u2026 https:\/\/t.co\/IHdBTN3hdI","userName":"@JamayBeebe","message":"Will institutions make CX or payments \u2018plumbing\u2019 their business? Alie Hoover, @PwCUS's Banking Transformation Leade\u2026 https:\/\/t.co\/IHdBTN3hdI","link":"https:\/\/twitter.com\/JamayBeebe\/status\/1381695183541084160","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@PwCUS","createTime":"<b>@PwCUS<\/b> was asked by <b>@DonaldPJames - 2021-04-12 21:30:10<\/b><br \/> Will institutions make CX or payments \u2018plumbing\u2019 their business? Alie Hoover, @PwCUS's Banking Transformation Leade\u2026 https:\/\/t.co\/4D5QUduQyX","userName":"@DonaldPJames","message":"Will institutions make CX or payments \u2018plumbing\u2019 their business? Alie Hoover, @PwCUS's Banking Transformation Leade\u2026 https:\/\/t.co\/4D5QUduQyX","link":"https:\/\/twitter.com\/DonaldPJames\/status\/1381691130224373760","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@JesusFlores_CA - 2021-04-12 20:47:21<\/b><br \/> What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/CglIsnEPLJ https:\/\/t.co\/fzdTRcN5EN","userName":"@JesusFlores_CA","message":"What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/CglIsnEPLJ https:\/\/t.co\/fzdTRcN5EN","link":"https:\/\/twitter.com\/JesusFlores_CA\/status\/1381680354096939009","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@JoeBailitz - 2021-04-12 20:43:02<\/b><br \/> What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/u89kfZ5kdh https:\/\/t.co\/i9iSPJg73U","userName":"@JoeBailitz","message":"What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/u89kfZ5kdh https:\/\/t.co\/i9iSPJg73U","link":"https:\/\/twitter.com\/JoeBailitz\/status\/1381679267042353153","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@PwCUS","createTime":"<b>@PwCUS<\/b> was asked by <b>@zack_capozzi - 2021-04-12 19:46:50<\/b><br \/> @PwCUS what is the PwC MPS Team?","userName":"@zack_capozzi","message":"@PwCUS what is the PwC MPS Team?","link":"https:\/\/twitter.com\/zack_capozzi\/status\/1381665125246046212","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@DeloitteUS","createTime":"<b>@DeloitteUS<\/b> was asked by <b>@MHolland_VA - 2021-04-12 19:20:24<\/b><br \/> 12:15, what are you just going to sit there w\/ a Vodka Tonic, Tom Davis, @DeloitteUS? Am I the only one thinking Ba\u2026 https:\/\/t.co\/xghWT2Q3L0","userName":"@MHolland_VA","message":"12:15, what are you just going to sit there w\/ a Vodka Tonic, Tom Davis, @DeloitteUS? Am I the only one thinking Ba\u2026 https:\/\/t.co\/xghWT2Q3L0","link":"https:\/\/twitter.com\/MHolland_VA\/status\/1381658471859372034","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@PwCUS","createTime":"<b>@PwCUS<\/b> was asked by <b>@DonaldPJames - 2021-04-12 19:20:04<\/b><br \/> Will institutions make CX or payments \u2018plumbing\u2019 their business? Alie Hoover, @PwCUS's Banking Transformation Leade\u2026 https:\/\/t.co\/xeuHjmjBj2","userName":"@DonaldPJames","message":"Will institutions make CX or payments \u2018plumbing\u2019 their business? Alie Hoover, @PwCUS's Banking Transformation Leade\u2026 https:\/\/t.co\/xeuHjmjBj2","link":"https:\/\/twitter.com\/DonaldPJames\/status\/1381658386639380482","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@lhvanorden - 2021-04-12 19:02:41<\/b><br \/> What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/nZhCPsUWey https:\/\/t.co\/8SBDxaBwnO","userName":"@lhvanorden","message":"What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/nZhCPsUWey https:\/\/t.co\/8SBDxaBwnO","link":"https:\/\/twitter.com\/lhvanorden\/status\/1381654013716819968","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@PwCUS","createTime":"<b>@PwCUS<\/b> was asked by <b>@Frozen2late - 2021-04-12 17:44:52<\/b><br \/> Where should I go on vacation?? \n@PwCUS has started offering workers 0 for every week they take off, up to four\u2026 https:\/\/t.co\/ITCB4Kqo3S","userName":"@Frozen2late","message":"Where should I go on vacation?? \n@PwCUS has started offering workers $250 for every week they take off, up to four\u2026 https:\/\/t.co\/ITCB4Kqo3S","link":"https:\/\/twitter.com\/Frozen2late\/status\/1381634432487030785","retweets":"0","favs":"1","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@EY_US","createTime":"<b>@EY_US<\/b> was asked by <b>@mEnablingSummit - 2021-04-12 17:30:00<\/b><br \/> Are you striving for a #digitallyinclusive workplace? Get the inside scoop from @EY_US observations made by employe\u2026 https:\/\/t.co\/bn2EkkoXor","userName":"@mEnablingSummit","message":"Are you striving for a #digitallyinclusive workplace? Get the inside scoop from @EY_US observations made by employe\u2026 https:\/\/t.co\/bn2EkkoXor","link":"https:\/\/twitter.com\/mEnablingSummit\/status\/1381630690995789829","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@SteveHill_SI - 2021-04-12 17:29:41<\/b><br \/> What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/F0Tlk8Eiwq https:\/\/t.co\/5ndoQHGmDy","userName":"@SteveHill_SI","message":"What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/F0Tlk8Eiwq https:\/\/t.co\/5ndoQHGmDy","link":"https:\/\/twitter.com\/SteveHill_SI\/status\/1381630609118748674","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@anilballa - 2021-04-12 16:55:30<\/b><br \/> What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/vyR6lvCMKh https:\/\/t.co\/FkKd1CPZ2v","userName":"@anilballa","message":"What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report https:\/\/t.co\/vyR6lvCMKh https:\/\/t.co\/FkKd1CPZ2v","link":"https:\/\/twitter.com\/anilballa\/status\/1381622007993827332","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@juliacognetti - 2021-04-12 16:39:41<\/b><br \/> \ud83e\udd1a Need tax help with #ASC740? Read the updated guide from @KPMG_US Department of Professional Practice \u2013 explaining\u2026 https:\/\/t.co\/fSlke7HRu2","userName":"@juliacognetti","message":"\ud83e\udd1a Need tax help with #ASC740? Read the updated guide from @KPMG_US Department of Professional Practice \u2013 explaining\u2026 https:\/\/t.co\/fSlke7HRu2","link":"https:\/\/twitter.com\/juliacognetti\/status\/1381618028517892100","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"},{"pageName":"@KPMG_US","createTime":"<b>@KPMG_US<\/b> was asked by <b>@DRussellGrant - 2021-04-12 15:55:08<\/b><br \/> What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report. #Biopharmaceuticals #Innovation\u2026 https:\/\/t.co\/HBHZ56T4Ok","userName":"@DRussellGrant","message":"What\u2019s in store for pharma deals in 2021? Find out in this @KPMG_US report. #Biopharmaceuticals #Innovation\u2026 https:\/\/t.co\/HBHZ56T4Ok","link":"https:\/\/twitter.com\/DRussellGrant\/status\/1381606814458896388","retweets":"0","favs":"0","respTime":"n\/a","timeToRespond":"n\/a"}]}]